Lytic Complications after Skull Reconstruction Using GeneX®

Area of Science:

• Orthopedic surgery
• Biomaterials science
• Regenerative medicine

Background:

• Bone graft substitutes are increasingly utilized for bone defect reconstruction.
• GeneX® is a bone graft substitute composed of calcium sulfate and β-tricalcium phosphate.
• Its application in skull defect reconstruction is a recent development.

Observation:

• This report details three patient cases involving GeneX® for skull defect reconstruction.
• Complications observed included wound inflammation and serous cyst formation.
• These adverse events occurred post-implantation of the GeneX® material.

Findings:

• GeneX® use was associated with significant complications in the observed cases.
• Wound inflammation and serous cysts represent potential adverse outcomes.
• The specific composition of GeneX® (calcium sulfate and β-tricalcium phosphate) may be implicated.

Implications:

• Clinical use of GeneX® requires careful consideration of potential risks.
• Further investigation into the safety and efficacy of GeneX® is warranted.
• Alternative or modified bone graft materials may be necessary for certain applications.